University of Tennessee Health Science Center Campus Photos
WebMail  /  SiteMap  /  Contact Information

Department of Urology

 

Contact Information

 
Department of Urology


Department Chair
Robert W. Wake, M.D.

910 Madison Avenue,
Room 409
Memphis, Tennessee 38163
Phone:901-448-1026
Fax: 901-448-1122

Executive Dean:
Steve J. Schwab, M.D.

Welcome to the Department of Urology


Urology Publications - 1997

Clinical Trials

 

 

“CYTOKINE AND TUMOR MARKER PROFILES OF RENAL TUMORS UNDERGOING EXTRIPATION AND ENERGY-ABLATIVE THERAPY” Ithaar H. Derweesh, M.D. (PI) and Lawrence Pfeffer, Ph.D. (Co-PI)

Status: Undergoing Patient Recruitment, Opened August 2007.

 

VA Cooperative Studies Program Protocol 553, “ADJUVANT DOCETACEL FOR HIGH RISK DISEASE POST-PROSTATECTOMY”

Ithaar H. Derweesh, M.D. (Site Co-PI); Andrew Liman (Site Co-PI)

Status: On-going, with active enrollment, approved March 2007.

 

“ACAPODENE™ (toremifene citrate) FOR THE REDUCTION IN THE INCIDENCE OF PROSTATE CANCER IN MEN WITH HIGH GRADE PROSTATIC INTRAEPITHELIAL NEOPLASIA (PIN)” Study sponsored by GTx, Inc., Memphis, TN.

Ithaar H. Derweesh, M.D. (Site PI)

Status: On-going, enrollment closed, May 2007.

 

“THE ASSURE TRIAL—ADJUVANT SUNITINIB VERSUS SORAFENIB VERSUS PLACEBO IN PATIENTS WITH RESECTED RENAL CELL CARCINOMA”

Ithaar H. Derweesh, M.D. (Site Co-PI); Mohammed Jahanzeb, M.D. (Site PI)

Status: On-going enrollment.

 

“SELENIUM AND VITAMIN E CANCER PREVENTION (SELECT) TRIAL”

Robert W. Wake, M.D. (Site PI). Ithaar H. Derweesh, M.D. (Site co-PI)

Status: Closed to enrollment. Patients being followed.

 

“SOCIETY FOR FETAL UROLOGY PRENATAL HYDRONEPHROSIS REGISTRY”

H. Norman Noe, M.D., Mark A. Williams, M.D. and Dana Giel, M.D.

 

“RANDOMIZED PROSPECTIVE EVALUATION OF THE INCIDENCE OF FEBRILE UTI AFTER TREATMENT OF PIC POSITIVE OCCULT VESICOURETERAL REFLUX”

H. Norman Noe, M.D., Mark A. Williams, M.D. and Dana Giel, M.D.

 

“PIC CYSTOGRAMS IN PATIENTS WITH FEBRILE UTIs THOUGHT TO HAVE RESOLVED VESICOURETERAL REFLUX”

H. Norman Noe, M.D. (P.I.)

 

A PROSPECTIVE MULTICENTER REGISTRY OF SALVAGE CRYOTHERAPY IN RECURRENT PROSTATE CANCER STUDY “THE COLD REGISTRY””

Robert W. Wake, M.D. (Site PI). Ithaar Derweesh, M.D. (Site co-PI)

Status: Open to enrollment November 2007.

 

“COMPARISON OF TRANSURETHRAL RESECTION OF THE PROSTATE (TURP) WITH AND WITHOUT SIMULTANEOUS REAL-TIME TRANSRECTAL ULTRASOUND (TRUS) IMAGING” 

Michael A. Aleman, M.D. (PI)

 

“COMPARISON OF TRANS-PERINEAL AND TRANS-OBTURATOR MALE/URETHRAL SLING FOR STRESS URINARY INCONTINENCE FOLLOWING RADICAL PROSTATECTOMY”

Michael A. Aleman, M.D. (PI).  Robert W. Wake, M.D. (co-PI)

 

“CESSATION OF LONG-TERM ALPHA BLOCKADE: THE COLA TRIAL” 

Michael A. Aleman, M.D. (PI)

 

“A PHASE 2, 16 WEEK, MULTICENTER, RANDOMIZED, DOUBLE BLIND PLACEBO-CONTROLLED, PARALLEL GROUP PROOF OF CONCEPT STUDY EVALUATING THE EFFICACY AND SAFETY OF TANEZUMAB FOR THE TREATMENT OF PAIN ASSOCIATED WITH CHRONIC ABACTERIAL PROSTATITIS”  Sponsor: Pfizer; Anthony L. Patterson, M.D. (P.I.)

Status: On-going enrollment.